Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03895671
Title PONAZA : A COMBINATION OF PONATINIB AND 5-AZACITIDINE IN CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST CRISIS (PONAZA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Versailles Hospital
Indications

chronic myeloid leukemia

Therapies

Azacitidine + Ponatinib

Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.